Palliative endobronchial brachytherapy for non-small cell lung cancer

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2008, Pages

  Cardona, A F ^b   Reveiz, Ludovic ^a   Ospina, E G ^b   Ospina, V ^b   Yepes, A ^b  

^a Instituto de Investigaciones   (Colombia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COUGHING; DYSPNEA; EXTERNAL BEAM RADIOTHERAPY; HEMOPTYSIS; HUMAN; LUNG NON SMALL CELL CANCER; META ANALYSIS; NEODYMIUM LASER; PALLIATIVE THERAPY; RADIATION DOSE; REVIEW; SHOULDER PAIN; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW; THORAX PAIN; TREATMENT OUTCOME;

EID: 44949203683     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004284.pub2     Document Type: Review

References (63)

1. Baas 1994 {published data only} Baas P. Photodynamic therapy and/or endobronchial irradiation as pretreatment in external radiation therapy for patients with inoperable non-small cell lung cancer: an interim analysis. European Journal of Cancer. 1994; Vol. 30, issue Suppl 1:33.
2. Barber 1993 {published data only} Barber P, Stout R, Burt P. Radiotherapy for inoperable lung cancer: a randomized comparison of fractionated luminal radiotherapy (ILT). European Respiratory Journal. 1993; Vol. 6, issue Suppl 17:395.
3. Calaguas 1997 {published data only} Calaguas MJC, Barretto LB, Leonardia RR. High dose rate endobronchial brachytherapy for bronchogenic carcinoma: The lung center of the Philippines experience: A preliminary report. Lung Cancer. 1997; Vol. 18, issue Suppl 1:131.
4. Chella 2000 {published data only} Chella A, Ambrogi MC, Ribechini A, Mussi A, Fabrini MG, Silvano G, et al.Combined Nd-YAG laser/HDR brachytherapy versus Nd-YAG laser only in malignant central airway involvement: a prospective randomized study. Lung Cancer 2000;27(3):169-75.
5. Ferstl 1997 {published data only} Ferstl A, Fischer R, Hautmann H, Pollinger B, Hausinger K, Huber RM. Simultaneous chemotherapy and high dose rate brachytherapy (HDRBT) in the treatment of locally advanced non-small cell lung cancer. European Respiratory Journal. 1997; Vol. 10, issue suppl 25: 198S.
6. Huber 1995 {published data only} *Huber RM, Fischer R, Hautmann H, Pollinger B, Wendt T, Muller-Wening D, Haussinger K. Palliative endobronchial brachytherapy for central lung tumors. A prospective, randomized comparison of two fractionation schedules. Chest 1995;107(2):463- 70.
7. Huber 1997 {published data only} Huber RM, Fischer R, Hautmann H, Pollinger B, Haussinger K, Wendt T. Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors. International Journal of Radiation Oncology, Biology, Physics 1997;38(3):533-40.
8. Langendijk 2001 {published data only} Langendijk H, de Jong J, Tjwa M, Muller M, ten Velde G, Aaronson N, et al.External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Radiotherapy and Oncology 2001;58 (3):257-68.
9. Moghissi 1999 {published data only} Moghissi K, Bond MG, Sambrook RJ, Stephens RJ, Hopwood P, Girling DJ. Treatment of endotracheal or endobronchial obstruction by non-small cell lung cancer: lack of patients in an MRC randomized trial leaves key questions unanswered. Medical Research Council Lung Cancer Working Party. Clinical Oncology 1999;11:3179-83.
10. Poellinger 2000 {published data only} Poellinger B, Huber RM, Fischer R, Hautmann H, Siefert A, Duehmke E. High-dose rate brachytherapy (HDR-BT): a prospective randomized trial of two fractionation schedules in the palliative treatment of central lung tumours. International Journal of Radiation Oncology, Biology, Physics 2000;48(3 Suppl 1):244.
11. Sharma 1998 {published data only} Sharma SC, Beriwal S. Prospective comparative study of external radiation plus HDR endobronchial brachytherapy versus external radiation alone in the palliative treatment of Bronchogenic Carcinoma. Radiotherapy and Oncology. 1998; Vol. 48, issue Suppl 1:210.
12. Stout 2000 {published data only} Stout R, Barber P, Burt P, Hopwood P, Swindell R, Hodgetts J, et al.Clinical and quality of life outcomes in the first United Kingdom randomized trial of endobronchial brachytherapy (intraluminal radiotherapy) vs. external beamradiotherapy in the palliative treatment of inoperable non-small cell lung cancer. Radiotherapy and Oncology 2000;56(3):323-7.
13. Sur 2004 {published data only} Sur R, Donde B, Mohuiddin M, Ahmed N, Pacella J, Mohamed G, et al.Randomized prospective study on the role of high dose rate intraluminal brachytherapy (HDRILBT) in palliation of symptoms in advanced non small cell lung cancer (NSCLC) treated with radiation alone. International Journal of Radiation Oncology, Biology, Physics 2004;60(1 Suppl 1):A127.
14. Anacak 2001 Anacak Y, Mogulkoc N, Ozkok S, Goksel T, Haydaroglu A, Bayindir U. High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer. Lung Cancer 2001;34(2):253-9.
15. Bedwinek 1992 Bedwinek J, Petty A, Bruton C, Sofield J, Lee L. The use of high dose rate endobronchial brachytherapy to palliate symptomatic endobronchial recurrence of previously irradiated bronchogenic carcinoma. International Journal of Radiation Oncology, Biology, Physics 1992;22(1):23-30.
16. Burt 1990 Burt PA, O'Driscoll BR, Notley HM, Barber PV, Stout R. Intraluminal irradiation for the palliation of lung cancer with the high dose rate micro-Selectron. Thorax 1990;45(10):765-8.
17. Delclos 1996 Delclos ME, Komaki R, Morice RC, Allen PK, Davis M, Garden A. Endobronchial brachytherapy with high-dose-rate remote after loading for recurrent endobronchial lesions. Radiology 1996;201(1):279-82.
18. EscobarSacristan2004 Escobar-Sacristan JA, Granda-Orive JI, Gutierrez JT, Delgado JM, Rodero BA, Saez VR. Endobronchial brachytherapy in the treatment of malignant lung tumours. European Respiratory Journal 2004;24 (3):348-52.
19. Fass 1990 Fass DE, Armstrong J, Harrison LB. Fractionated high dose rate endobronchial treatment for recurrent lung cancer. Endocurie Hyperther Oncol 1990;6:211-5.
20. Freitag 2004 Freitag L, Ernst A, Thomas M, Prenzel R, Wahlers B, Macha HN. Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma. Thorax 2005;59(9):790-3.
21. Gauwitz 1992 Gauwitz M, Ellerbroek N, Komaki R, Putnam JBJr, Ryan MB, DeCaro L, et al.High dose endobronchial irradiation in recurrent bronchogenic carcinoma. International Journal of Radiation Oncology, Biology, Physics 1992;23(2):397-400.
22. Gejerman 2002 Gejerman G, Mullokandov EA, Bagiella E, Blaivas A, Beitler JJ. Endobronchial brachytherapy and external-beam radiotherapy in patients with endobronchial obstruction and extrabronchial extension. Brachytherapy 2002;1(4):204-10.
23. Goldman 1993 Goldman JM, Bulman AS, Rathmell AJ, Carey BM, Muers MF, Joslin CAF. Physiological effect of endobronchial radiotherapy in patients with major airway occlusion by carcinoma. Thorax 1993;48(2):110-4.
24. Hernandez 1996 Hernandez P, Gursahaney A, Roman T, Schwartzman K, Donath D, Cosio MG, et al.High dose rate brachytherapy for the local control of endobronchial carcinoma following external irradiation. Thorax 1996;51(4):354-8.
25. Hopwood 1997 Hopwood P, R Swindell, P Burt, R. Stout, P Barber. Clinically relevant quality of life outcomes in the first UK randomised trial of endobronchial brachytherapy (EBT) versus external beam radiotherapy (XRT) in patients with inoperable non-small cell cancer (NSCLC). Lung Cancer 1997;18(Suppl 1):130.
26. Huber 1990 Huber RM, Wendt T, Pforte A, Heinz S, Hautmann H, Gassner F, Muller-Wining D, Haussinger K. Additional effect of high dose rate endoluminal irradiation (AL) in patients with central lung tumours: preliminary results of a randomized study. European Respiratory Journal. 1990; Vol. 3, issue Suppl 10:221.
27. Mehta 1992 Mehta M, Petereit D, Chosy L, Harmon M, Fowler J, Shahabi S, et al.Sequential comparison of low dose rate and hyperfractionated high dose rate endobronchial radiation for malignant airway occlusion. International Journal of Radiation Oncology, Biology, Physics 1992;23(1):133-9.
28. Ofiara 1997 Ofiara L, Roman T, Schwartzman K, Levy RD. Local determinants of response to endobronchial high-dose rate brachytherapy in bronchogenic carcinoma. Chest 1997;112(4):946-53.
29. Ornadel 1997 Ornadel D, Duchesne G, Wall P, Ng A, Hetzel M. Defining the roles of high dose rate endobronchial brachytherapy and laser resection for recurrent bronchial malignancy. Lung Cancer 1997;16(2-3):203-13.
30. Perol 1997 Perol M, Caliandro R, Pommier P, Malet C, Montbarbon X, Carrie C, et al.Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study. Chest 1997;111(5):1417-23.
31. Pollinger 1996 Pollinger B, Huber RM, Fischer R, Siefert A, Kiszel Z, Busch M, Duhmke E. Prospective randomised trial on the role of HDR-brachytherapy in addition to external beam radiotherapy for central bronchial carcinoma. International Journal of Radiation Oncology, Biology, Physics 1996;36(Suppl 1):208.
32. Pollinger 1997 Pollinger B, Huber RM, Fischer R, Siefert A, Busch M, Kiszel Z, Duhmke E. HDR-brachytherapy und external irradiation by central inoperable lung tumours: prospective randomised comparison. Strahlentherapie und Onkologie 1997;173(11):572.
33. Speiser 1993 Speiser BL, Spratling L. Radiation bronchitis and stenosis secondary to high dose rate endobronchial irradiation. International Journal of Radiation Oncology, Biology, Physics 1993;25:589-97.
34. Speiser 1993 1 Speiser BL, Spratling L. Remote after loading brachytherapy for the local control of endobronchial carcinoma. International Journal of Radiation Oncology, Biology, Physics 1993;25(4):579-87.
35. Sutedja 1992 Sutedja G, Baris G, Schaake-Koning C, van Zandwijk N. High dose rate brachytherapy in patients with local recurrences after radiotherapy of non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics 1992;24(3):551-3.
36. Trédaniel 1994 Tredaniel J, Hennequin C, Zalcm.an G, Walter S, Homasson JP, Maylin C, et al.Prolonged survival after high-dose rate endobronchial radiation for malignant airway obstruction. Chest 1994;105(3):767-72.
37. Mogulkoc 2000 Mogulkoc N, Barber P, Burt P, Hopwood P, Hodgetts J, Lomax L, et al.A randomised comparison of the effect of external beam radiotherapy (ERT) and intraluminal radiotherapy (ILT) on pulmonary function in unresectable non-small cell lung cancer (NSCLC). European Respiratory Journal 2000;16(Suppl 31):48.
38. Sur 2001 Sur R, Ahmed SN, Donde B, Morar R, Mohamed G, Sur M, et al.Brachytherapy boost vs teletherapy boost in palliation of symptomatic, locally advanced non-small cell lung cancer: Preliminary analysis of a randomized, prospective study. Brachytherapy International 2001;17(4):309-15.
39. Becket 1993 Becket WS. Epidemiology and etiology of lung cancer. Clinics in Chest Medicine 1993;14:1-15.
40. Boyle 2000 Boyle P, Gandini S, Gray N. Epidemiology of lung cancer: a century of great success and ignominious failure. In:HansenH editor(s). IASLC Textbook of Lung Cancer. London: Martin Dunitz, 2000:13-26.
41. Burt 1987 Burt ME, Pomerantz AH, Bains MS, McCormack PM, Kaiser LR, Hilaris BS, Martini N. Results of surgical treatment of stage III lung cancer invading the mediastinum. The Surgical Clinics of North America 1987;67(5):987-1000.
42. Castro 1999 Castro AA, Clark OAC, Atallah AN. Optimal search strategy for clinical trials in the Latin American and Caribbean Health Science Literature Database (LILACS database): Update. Sao Paulo Med 1999;117:3.
43. Chang 1994 Chang LF, Horvath J, Peyton W, Ling SS. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer. Int J Radiat Oncol Biol Phys 1994;28(3):589-96.
44. Dinshaw 1991 Dinshaw KA, Sharma V, Pendse AM, Telang CS, Vege SS, Malliat MK, et al.The role of intraluminal radiotherapy and concurrent 5-fluorouracil infusion in the management of carcinoma esophagus: a pilot study. Journal of Surgical Oncology 1991;47(3):155-60.
45. Emami 1997 Emami B, Kaiser L, Simpson J, Shapiro S, Roper C, Lockett MA. Postoperative radiation therapy in non-small cell lung cancer. American Journal of Clinical Oncology 1997;20(5):441-8.
46. Globocan IARC 2002 Ferlay J, Bray F, Pisari P, Parkin DM. Globocan 2002. Cancer incidence, mortality and prevalence worldwide. wwwdep.iarc.fr/dataava/infodata.htm (accessed December 11 2006).
47. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. The Cochrane Library. UK: John Wiley & Sons, Ltd, 2005.
48. Hilaris 1994 Hilaris BS. Lung brachytherapy. An overviewand current indications. Chest Surgery Clinics of North America 1994;4(1):45-53.
49. Kovàcs 2001 Kovàcs G, RTOG-9207-Studie. Percutaneous radiotherapy plus brachytherapy and concurrent chemotherapy for patients with localized esophageal carcinoma - Radiation Oncology Group Study 9207. Strahlenther Onkologie 2001;177(5):269-70.
50. Kumar 2007 Kumar S, Dimri K, Khurana R, Rastogi N, Das KJ, Lal P. A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus. Radiotherapy and Oncology 2007;83(2):139-47.
51. Lester 2006 Lester JF, Macbeth FR, Toy E, Coles B. Palliative radiotherapy regimens for non-small cell lung cancer. Cochrane Database of Systematic Reviews 2006, Issue 2.Art. No.: CD002143. DOI:10.1002/14651858. CD002143.pub2.
52. Maher 1993 Maher EJ, Timothy A, Squire CJ, Goodman A, Karp SJ, Paine CH, et al.Audit: the use of radiotherapy for NSCLC in the UK. Clinical Oncology 1993;5(2):72-9.
53. Nag 2001 Nag S, Kelly JF, Horton JL, Komaki R, Nori D. Brachytherapy for carcinoma of the lung. Recommendations from the American Brachytherapy Society. Oncology (Huntington) 2001;15(3):371-81.
54. NSCLC 1995 Non-small cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 1995;311:899-909.
55. Paradelo 1992 Paradelo JC, MJ Waxman, BJ Throne, TA Beller, WJ Kopecky. Endobronchial irradiation with 192Ir in the treatment of malignant endobronchial obstruction. Chest 1992;102(4):1072-4.
56. Perez 1992 Perez CA, Brady LW, editors. Principles and Practice of Radiation Oncology. 2nd Edition. Philadelphia: JB Lippincott Co, 1992:50-63; 114-23.
57. Schray 1988 Schray MF, McDougall JC, Martinez A, Cortese DA, Brutinel WM. Management of malignant airway compromise with laser and low dose rate brachytherapy: the Mayo Clinic experience. Chest 1988;93(2):264-9.
58. Seagren 1985 Seagren SL, Harrell JH, Horn RA. High dose rate intraluminal irradiation in recurrent endobronchial carcinoma. Chest 1985;88(6):810-4.
59. Shaw 1993 Shaw EG, Bonner JA, Foote RL, Martenson JA Jr, Frytak S, Deschamps C, et al.Role of radiation therapy in the management of lung cancer. Mayo Clinic Proceedings 1993;68(6):593-602.
60. Sirzén 2003 Sirzén F, Kjellén E, Sörenson S, Cavallin-Stahl E. A systematic overview of radiation therapy effects in non-small cell lung cancer. Acta Oncol 2003;42(5-6): 493-515.
61. Speiser 1999 Speiser BL. Brachytherapy in the treatment of thoracic tumors. Lung and esophageal. Hematology/Oncology Clinics of North America 1999;13(3):609-34.
62. Teo 1999 Teo PM, Chan AT, Lee WY, Leung TW, Johnson PJ. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy. International Journal of Radiation Oncology, Biology, Physics 1999;43(2):261-71.
63. Ung 2006 Ung YC, Yu E, Falkson C, Haynes AE, Stys-Norman D, Evans WK, Lung Cancer Disease Site Group Of Cancer Care Ontario's Program In Evidence-Based Care. The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non-small-cell lung cancer: a systematic review. Brachytherapy 2006;5(3):189-202.